BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 234993)

  • 1. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.
    Musher DM; Griffith DP; Yawn D; Rossen RD
    J Infect Dis; 1975 Feb; 131(2):177-81. PubMed ID: 234993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of acetohydroxamic acid on experimental proteus pyelonephritis.
    Maclaren DM
    Invest Urol; 1974 Sep; 12(2):146-9. PubMed ID: 4605277
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
    Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K
    Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE; Russell RG; Lockatell CV; Zulty JC; Warren JW; Mobley HL
    Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of acetohydroxamic acid on experimental Corynebacterium renale pyelonephritis.
    Jerusik RJ; Kadis S; Chapman WL; Wooley RE
    Can J Microbiol; 1977 Oct; 23(10):1448-55. PubMed ID: 21738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP; Gibson JR; Clinton CW; Musher DM
    J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further observations on the potentiation of the antibacterial effect of methenamine by acetohydroxamic acid.
    Musher DM; Griffith DP; Templeton GB
    J Infect Dis; 1976 May; 133(5):564-7. PubMed ID: 4573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of urinary catheter incrustations by acetohydroxamic acid.
    Burns JR; Gauthier JF
    J Urol; 1984 Sep; 132(3):455-6. PubMed ID: 6381758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.
    Takeuchi H; Okada Y; Kobashi K; Yoshida O
    Urol Res; 1982; 10(4):217-9. PubMed ID: 6758273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    J Urol; 1984 Oct; 132(4):795-9. PubMed ID: 6381769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of urease as chemotherapeutic agents.
    Rosenstein IJ; Hamilton-Miller JM
    Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid.
    Musher DM; Griffith DP; Tyler M; Woelfel A
    Antimicrob Agents Chemother; 1974 Feb; 5(2):101-5. PubMed ID: 4840424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.